ursodeoxycholic acid has been researched along with acetylcysteine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Niu, N; Smith, BF | 1 |
| Salmerón Escobar, FJ | 1 |
| Giostra, E; Malè, PJ | 1 |
| Attali, M; Borchardt, J; Mahlab, K; Malnick, SD; Sokolowski, N | 1 |
| Al-Osaimi, AM; Argo, CK; Caldwell, SH; Chang, CY | 1 |
| Dhawan, A; Dziechciarz, P; Horvath, A; Socha, P; Szajewska, H; Vajro, P | 1 |
| Cooper, J; Webster, CR | 1 |
| Akkiz, H; Cosar, A; Kece, C; Ozdil, B; Sandikci, M | 1 |
| Li, YC; Zhou, TF | 1 |
| Abakumov, VZ; Belonovskaia, EB; Buko, VU; Lukivskaia, OIa; Naruta, EE | 1 |
| Clemens, DL; Dey, A; Kumar, SM; Swaminathan, K | 1 |
| Abdel-Latif, HA; Ali, MH; Messiha, BA | 1 |
| Cotrim, HP; Oliveira, CP; Parise, ER; Salgado, ALA; Siqueira, ACG; Stefano, JT | 1 |
| Björklund, A; El-Serafi, I; Mattsson, J; Remberger, M; Ringdèn, O; Sundin, M; Törlén, J; Winiarski, J | 1 |
| Aithal, GP; Alvarez-Alvarez, I; Andrade, RJ; Arikan, C; Atallah, E; Lucena, MI; Medina-Caliz, I; Niu, H | 1 |
7 review(s) available for ursodeoxycholic acid and acetylcysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Alternative treatment to interferon therapy in chronic viral hepatitis].
Topics: Acetylcysteine; Adjuvants, Immunologic; Antisense Elements (Genetics); Antiviral Agents; Cholagogues and Choleretics; Hepatitis B; Hepatitis C; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Interferon Inducers; Poly A-U; RNA, Catalytic; Ursodeoxycholic Acid | 1995 |
[Treatment of viral hepatitis C: what are the perspectives?].
Topics: Acetylcysteine; Adult; Age Factors; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Ketoprofen; Male; Middle Aged; Prognosis; Ribavirin; Sex Factors; Time Factors; Ursodeoxycholic Acid | 1994 |
Therapy of NAFLD: antioxidants and cytoprotective agents.
Topics: Acetylcysteine; Antioxidants; Betaine; Cholagogues and Choleretics; Disease Progression; Fatty Liver; Humans; Lipid Peroxidation; S-Adenosylmethionine; Ursodeoxycholic Acid; Vitamin E | 2006 |
Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review.
Topics: Acetylcysteine; Adult; Alanine Transaminase; Aspartate Aminotransferases; Carnitine; Child; Dietary Supplements; Drug Synergism; Drug Therapy, Combination; Fatty Liver; Humans; Hypoglycemic Agents; Liver; Metformin; Pioglitazone; Probucol; Randomized Controlled Trials as Topic; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E | 2009 |
Therapeutic use of cytoprotective agents in canine and feline hepatobiliary disease.
Topics: Acetylcysteine; Animals; Antioxidants; Biliary Tract Diseases; Cat Diseases; Cats; Cholagogues and Choleretics; Cryoprotective Agents; Dog Diseases; Dogs; Free Radical Scavengers; Liver Diseases; S-Adenosylmethionine; Silymarin; Ursodeoxycholic Acid; Vitamin E | 2009 |
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review.
Topics: Acetaminophen; Acetylcysteine; Adolescent; Adrenal Cortex Hormones; Adult; Carnitine; Chemical and Drug Induced Liver Injury; Child; Drug-Related Side Effects and Adverse Reactions; Glutathione; Glycyrrhizic Acid; Humans; Infant, Newborn; Liver; Liver Failure, Acute; Retrospective Studies; S-Adenosylmethionine; Ursodeoxycholic Acid | 2022 |
1 trial(s) available for ursodeoxycholic acid and acetylcysteine
| Article | Year |
|---|---|
N-ACETYLCYSTEINE AND/OR URSODEOXYCHOLIC ACID ASSOCIATED WITH METFORMIN IN NON-ALCOHOLIC STEATOHEPATITIS: AN OPEN-LABEL MULTICENTER RANDOMIZED CONTROLLED TRIAL.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Humans; Male; Metformin; Middle Aged; Non-alcoholic Fatty Liver Disease; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2019 |
12 other study(ies) available for ursodeoxycholic acid and acetylcysteine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Addition of N-acetylcysteine to aqueous model bile systems accelerates dissolution of cholesterol gallstones.
Topics: Acetylcysteine; Animals; Bile; Cattle; Cholelithiasis; Cholesterol; Expectorants; Humans; In Vitro Techniques; Taurocholic Acid; Ursodeoxycholic Acid | 1990 |
Acute cholestatic hepatitis after exposure to isoflurane.
Topics: Acetylcysteine; Acute Disease; Aged; Anesthetics, Inhalation; Biopsy; Chemical and Drug Induced Liver Injury; Cholestasis; Female; Humans; Isoflurane; Liver; Liver Function Tests; Ursodeoxycholic Acid | 2002 |
New therapeutic option with N-acetylcysteine for primary sclerosing cholangitis: two case reports.
Topics: Acetylcysteine; Adult; Cholagogues and Choleretics; Cholangitis, Sclerosing; Female; Free Radical Scavengers; Humans; Liver; Male; Ursodeoxycholic Acid; Young Adult | 2011 |
[Three schistosomiasis patients combined with acute hepatitis E].
Topics: Acetylcysteine; Drug Therapy, Combination; Drugs, Chinese Herbal; Hepatitis E; Humans; Male; Middle Aged; Schistosomiasis; Ursodeoxycholic Acid | 2011 |
[Preventive administration of new UDCA derivatives in experimental alcoholic steatohepatitis].
Topics: Acetylcysteine; Alkaline Phosphatase; Animals; Cholagogues and Choleretics; Diet; Ethanol; Fatty Liver, Alcoholic; Female; gamma-Glutamyltransferase; Liver; Protective Agents; Rats; Rats, Wistar; Triglycerides; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2013 |
GSH protects against oxidative stress and toxicity in VL-17A cells exposed to high glucose.
Topics: Acetylcysteine; Alcohol Dehydrogenase; Antimetabolites; Antioxidants; Apoptosis; Buthionine Sulfoximine; Cell Survival; Clone Cells; Cytochrome P-450 CYP2E1; Glucose; Glutathione; Hep G2 Cells; Hepatocytes; Humans; Hyperglycemia; Lactoylglutathione Lyase; Maleates; Oxidative Stress; Reactive Oxygen Species; Recombinant Proteins; Ursodeoxycholic Acid | 2015 |
Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.
Topics: Acetylcysteine; Animals; Antioxidants; Biomarkers; Choline Deficiency; Cytoprotection; Disease Models, Animal; Hypolipidemic Agents; Lipids; Liver; Male; Methionine; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats, Wistar; Resveratrol; Stilbenes; Ursodeoxycholic Acid | 2016 |
Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Acetylcysteine; Adolescent; Adult; Busulfan; Capillaries; Child; Child, Preschool; Cholagogues and Choleretics; Cyclophosphamide; Drug Monitoring; Female; Free Radical Scavengers; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Incidence; Infant; Liver; Male; Middle Aged; Myeloablative Agonists; Retrospective Studies; Risk Assessment; Transplantation Conditioning; Ursodeoxycholic Acid; Young Adult | 2020 |